Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2003

01.10.2003 | Original Article

Post-operative complications after caesarean section in HIV-infected women

verfasst von: Simone Ferrero, Giorgio Bentivoglio

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2003

Einloggen, um Zugang zu erhalten

Abstract.

This retrospective study evaluated complications associated with caesarean section in HIV-infected women. For each HIV-positive patient (n=45) a control group of ten seronegative women (n=450) was matched for age, number of foetuses, gestational age, indication for caesarean section, status of the membranes and kind of anaesthesia. All women delivered in the same hospital using a uniform protocol. We evaluated the duration of stay in hospital after operation, the need for antibiotics after caesarean section, the incidence of minor postoperative complications (mild anaemia, mild temperature or fever 24 h after surgery, wound haematoma or infection, urinary tract infection, endometritis) and major postoperative complications (severe anaemia, pneumonia, pleural effusion, peritonitis, sepsis, disseminated intravascular coagulation, thromboembolism). Most HIV-positive women (64.5%) had a complicated recovery after surgery. A higher incidence of major and minor postoperative complications were observed in the HIV-positive group than in the control group. There was a statistically significant greater incidence of mild anaemia, mild temperature or fever, urinary tract infection and pneumonia in the HIV-positive group. HIV-positive women with less than 500×106 CD4+ lymphocytest/l had higher post-caesarean section morbidity than HIV-positive women with more than 500×106 CD4+ lymphocytest/l. The median duration of hospital stay was significantly higher in the HIV-positive group (median 7 days) than in the HIV-negative group (median 4 days). The rate of HIV vertical transmission was 8.8%. Higher post-caesarean section morbidity was found in HIV-positive women than in controls. Unfortunately, the HIV-positive women (with low CD4 lymphocytes counts), whose infants theoretically will benefit most from caesarean delivery, are also the women who are most likely to experience post-operative complications.
Literatur
1.
Zurück zum Zitat Bulterys M, Chao A, Dushimimana A, Saah A (1996) Fatal complications after cesarean section in HIV-infected women. AIDS 10:923–924 Bulterys M, Chao A, Dushimimana A, Saah A (1996) Fatal complications after cesarean section in HIV-infected women. AIDS 10:923–924
2.
Zurück zum Zitat Centers for Disease Control and Prevention (1994) Zidovudine for the prevention of HIV transmission from mother to infant. MMWR Morb Mortal Wkly Rep 43:285–287 Centers for Disease Control and Prevention (1994) Zidovudine for the prevention of HIV transmission from mother to infant. MMWR Morb Mortal Wkly Rep 43:285–287
3.
Zurück zum Zitat Centers for Disease Control and Prevention (1998) Public Health Service task force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in United States. MMWR Morb Mortal Wkly Rep 47:1–29 Centers for Disease Control and Prevention (1998) Public Health Service task force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in United States. MMWR Morb Mortal Wkly Rep 47:1–29
4.
Zurück zum Zitat Chuachoowong R, Shaffer N, Siriwasin W, Chaisilwattana P, Young NL, Mock PA, Chearskul S, Waranawat N, Chaowanachan T, Karon J, Simonds RJ, Mastro TD (2000) Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis 181:99–106 Chuachoowong R, Shaffer N, Siriwasin W, Chaisilwattana P, Young NL, Mock PA, Chearskul S, Waranawat N, Chaowanachan T, Karon J, Simonds RJ, Mastro TD (2000) Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis 181:99–106
5.
Zurück zum Zitat Clemetson DB, Moss GB, Willerford DM, Hensel M, Emonyi W, Holmes KK, Plummer F, Ndinya-Achola J, Roberts PL, Hillier S, Kreiss JK (1993) Detection of HIV DNA in cervical and vaginal secretions. JAMA 269:2860–2864 Clemetson DB, Moss GB, Willerford DM, Hensel M, Emonyi W, Holmes KK, Plummer F, Ndinya-Achola J, Roberts PL, Hillier S, Kreiss JK (1993) Detection of HIV DNA in cervical and vaginal secretions. JAMA 269:2860–2864
6.
Zurück zum Zitat Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, Bryson YJ (1996) Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. JAMA 275:599–605 Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, Bryson YJ (1996) Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. JAMA 275:599–605
7.
Zurück zum Zitat Dunn DT, Newell ML, Mayaux MJ, Kind C, Hutto C, Goedert JJ, Andiman W (1994) Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. J Acquir Immune Defic Syndr Hum Retrovirol 7:1064–1066 Dunn DT, Newell ML, Mayaux MJ, Kind C, Hutto C, Goedert JJ, Andiman W (1994) Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. J Acquir Immune Defic Syndr Hum Retrovirol 7:1064–1066
8.
Zurück zum Zitat European Collaborative Study (1994) Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 343:1464–1467 European Collaborative Study (1994) Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 343:1464–1467
9.
Zurück zum Zitat European Mode of Delivery Collaboration (1999) Elective caesarean section versus vaginal delivery in preventing vertical HIV-1 transmission: a randomised clinical trial. Lancet 353:1035–1039 European Mode of Delivery Collaboration (1999) Elective caesarean section versus vaginal delivery in preventing vertical HIV-1 transmission: a randomised clinical trial. Lancet 353:1035–1039
10.
Zurück zum Zitat Farrell SJ, Andersen HF, Work BA Jr (1980) Caesarean section: indications and postoperative morbidity. Obstet Gynecol 56:696–700 Farrell SJ, Andersen HF, Work BA Jr (1980) Caesarean section: indications and postoperative morbidity. Obstet Gynecol 56:696–700
11.
Zurück zum Zitat Green SL, Sarubbi FA Jr (1977) Risk factors associated with post caesarean section febrile morbidity. Obstet Gynecol 49:686–690 Green SL, Sarubbi FA Jr (1977) Risk factors associated with post caesarean section febrile morbidity. Obstet Gynecol 49:686–690
12.
Zurück zum Zitat Harger JH, English DH (1981) Selection of patients for antibiotic prophylaxis in cesarean section. Am J Obstet Gynecol 141:752–758 Harger JH, English DH (1981) Selection of patients for antibiotic prophylaxis in cesarean section. Am J Obstet Gynecol 141:752–758
13.
Zurück zum Zitat International Perinatal HIV Group (1999) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. A meta-analysis of 15 prospective cohort studies. N Engl J Med 340:977–987 International Perinatal HIV Group (1999) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. A meta-analysis of 15 prospective cohort studies. N Engl J Med 340:977–987
14.
Zurück zum Zitat John GC, Nduati RW, Mbori-Ngacha D, Overbaugh J, Welch M, Richardson BA, Ndinya-Achola J, Bwayo J, Krieger J, Onyango F, Kreiss JK (1997) Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamine A deficiency. J Infect Dis 175:57–62 John GC, Nduati RW, Mbori-Ngacha D, Overbaugh J, Welch M, Richardson BA, Ndinya-Achola J, Bwayo J, Krieger J, Onyango F, Kreiss JK (1997) Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamine A deficiency. J Infect Dis 175:57–62
15.
Zurück zum Zitat Kaneda T, Shiraki K, Hirano K, Nagata I (1997) Detection of maternofetal transfusion by placental alkaline phosphatase levels. J Pediatr 130:730–735 Kaneda T, Shiraki K, Hirano K, Nagata I (1997) Detection of maternofetal transfusion by placental alkaline phosphatase levels. J Pediatr 130:730–735
16.
Zurück zum Zitat La Raja RD, Rothenberg RE, Odom JW, Mueller SC (1989) The incidence of intra-abdominal surgery in acquired immunodeficiency syndrome: a statistical review of 904 patients. Surgery 105:175–179 La Raja RD, Rothenberg RE, Odom JW, Mueller SC (1989) The incidence of intra-abdominal surgery in acquired immunodeficiency syndrome: a statistical review of 904 patients. Surgery 105:175–179
17.
Zurück zum Zitat Loussert-Ajaka I, Mandelbrot L, Delmas MC, Bastian H, Benifla JL, Farfara I, de Vincenzi I, Matheron S, Simon F, Brun-Vezinet F (1997) HIV-1 detection in cervicovaginal secretions during pregnancy. AIDS 11:1575–1581 Loussert-Ajaka I, Mandelbrot L, Delmas MC, Bastian H, Benifla JL, Farfara I, de Vincenzi I, Matheron S, Simon F, Brun-Vezinet F (1997) HIV-1 detection in cervicovaginal secretions during pregnancy. AIDS 11:1575–1581
18.
Zurück zum Zitat Maiques-Montesinos V, Cervera-Sanchez J, Bellver-Pradas Jose, Abad-Carrascosa A, Serra-Serra Vincente (1999) Post-cesarean section morbidity in HIV-positive women. Acta Obstet Gynecol Scand 78:789–792 Maiques-Montesinos V, Cervera-Sanchez J, Bellver-Pradas Jose, Abad-Carrascosa A, Serra-Serra Vincente (1999) Post-cesarean section morbidity in HIV-positive women. Acta Obstet Gynecol Scand 78:789–792
19.
Zurück zum Zitat Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, Berrebi A, Benifla JL, Burgard M, Lachassine E, Barret B, Chaix ML, Bongain A, Ciraru-Vigneron N, Crenn-Hebert C, Delfraissy JF, Rouzioux C, Mayaux MJ, Blanche S 2001 Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 285:2083–2093 Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, Berrebi A, Benifla JL, Burgard M, Lachassine E, Barret B, Chaix ML, Bongain A, Ciraru-Vigneron N, Crenn-Hebert C, Delfraissy JF, Rouzioux C, Mayaux MJ, Blanche S 2001 Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 285:2083–2093
20.
Zurück zum Zitat Marcollet A, Goffinet F, Firtion G, Pannier E, Bret T, Brival ML, Mandelbrot L (2002) Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery. Am J Obstet Gynecol 186:784–789 Marcollet A, Goffinet F, Firtion G, Pannier E, Bret T, Brival ML, Mandelbrot L (2002) Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery. Am J Obstet Gynecol 186:784–789
21.
Zurück zum Zitat Newell ML (1998) Mechanism and timing of mother-to-child transmission of HIV-1. AIDS 12:831–837 Newell ML (1998) Mechanism and timing of mother-to-child transmission of HIV-1. AIDS 12:831–837
22.
Zurück zum Zitat Nielsen TF, Hökegard KH (1983) Postoperative cesarean section morbidity: a prospective study. Am J Obstet Gynecol 146:911–916 Nielsen TF, Hökegard KH (1983) Postoperative cesarean section morbidity: a prospective study. Am J Obstet Gynecol 146:911–916
23.
Zurück zum Zitat Parazzini F, for the European Mode of Delivery Colaboration (1999) Elective cesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised controlled trial. Lancet 352:1035–1039 Parazzini F, for the European Mode of Delivery Colaboration (1999) Elective cesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised controlled trial. Lancet 352:1035–1039
24.
Zurück zum Zitat Petitti DB, Cefalo RC, Shapiro S, Whalley P (1982) In hospital maternal mortality in the United States: time tends and relation to method of delivery. Obstet Gynecol 59:6–12 Petitti DB, Cefalo RC, Shapiro S, Whalley P (1982) In hospital maternal mortality in the United States: time tends and relation to method of delivery. Obstet Gynecol 59:6–12
25.
Zurück zum Zitat Rehu M, Nilsson C (1980) Risk factors for febrile morbidity associated with caesarean section. Obstet Gynecol 56:269–273 Rehu M, Nilsson C (1980) Risk factors for febrile morbidity associated with caesarean section. Obstet Gynecol 56:269–273
26.
Zurück zum Zitat Robinson G, Wilson SE, Williams RA (1987) Surgery in patients with acquired immunodeficiency syndrome. Arch Surg 122:170–175 Robinson G, Wilson SE, Williams RA (1987) Surgery in patients with acquired immunodeficiency syndrome. Arch Surg 122:170–175
27.
Zurück zum Zitat Rodriguez EJ, Spann C, Jamieson D, Lindsay M (2001) Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women. Am J Obstet Gynecol 184:1108–1111 Rodriguez EJ, Spann C, Jamieson D, Lindsay M (2001) Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women. Am J Obstet Gynecol 184:1108–1111
28.
Zurück zum Zitat Semprini AE, Castagna C, Ravizza M, Fiore S, Savasi V, Muggiasca ML, Grossi E, Guerra B, Tibaldi C, Scaravelli G, Prati E, Pardi G (1995) The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 9:913–917 Semprini AE, Castagna C, Ravizza M, Fiore S, Savasi V, Muggiasca ML, Grossi E, Guerra B, Tibaldi C, Scaravelli G, Prati E, Pardi G (1995) The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 9:913–917
29.
Zurück zum Zitat Tonnensen E, Wahlgreen C (1988) Influence of extradural and general anesthesia on natural killer cell activity and lymphocyte subpopulations in patients undergoing hysterectomy. Br J Anaesth 60:500–507 Tonnensen E, Wahlgreen C (1988) Influence of extradural and general anesthesia on natural killer cell activity and lymphocyte subpopulations in patients undergoing hysterectomy. Br J Anaesth 60:500–507
30.
Zurück zum Zitat Urbani G, de Vries MMJ, Cronjé HS, Niemand I, Bam RH, Beyer E (2001) Complications associated with cesarean section in HIV-infected patients. Int J Obstet Gynecol 74:9–15 Urbani G, de Vries MMJ, Cronjé HS, Niemand I, Bam RH, Beyer E (2001) Complications associated with cesarean section in HIV-infected patients. Int J Obstet Gynecol 74:9–15
31.
Zurück zum Zitat Vimercati A, Greco P, Loverro G, Lopalco PL, Pansini V, Selvaggi L (2000) Maternal complications after caesarean section in HIV infected women. Eur J Obstet Gynecol Reprod Biol 90:73–76 Vimercati A, Greco P, Loverro G, Lopalco PL, Pansini V, Selvaggi L (2000) Maternal complications after caesarean section in HIV infected women. Eur J Obstet Gynecol Reprod Biol 90:73–76
32.
Zurück zum Zitat Watts DH, Lambert JS, Stiehm ER, Bethel J, Whitehouse J, Fowler MG, Read J (2000) Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of <or =500/microL. Am J Obstet Gynecol 183:100–107 Watts DH, Lambert JS, Stiehm ER, Bethel J, Whitehouse J, Fowler MG, Read J (2000) Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of <or =500/microL. Am J Obstet Gynecol 183:100–107
Metadaten
Titel
Post-operative complications after caesarean section in HIV-infected women
verfasst von
Simone Ferrero
Giorgio Bentivoglio
Publikationsdatum
01.10.2003
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2003
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-002-0374-8

Weitere Artikel der Ausgabe 4/2003

Archives of Gynecology and Obstetrics 4/2003 Zur Ausgabe

Announcements

October 2003

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.